2-188997376-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 3P and 9B. PM1PP2BP6BS1BS2
The NM_000090.4(COL3A1):c.1856C>T(p.Pro619Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000182 in 1,613,526 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P619H) has been classified as Uncertain significance.
Frequency
Consequence
NM_000090.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
- Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polymicrogyria with or without vascular-type Ehlers-Danlos syndromeInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL3A1 | ENST00000304636.9 | c.1856C>T | p.Pro619Leu | missense_variant | Exon 26 of 51 | 1 | NM_000090.4 | ENSP00000304408.4 | ||
COL3A1 | ENST00000450867.2 | c.1757C>T | p.Pro586Leu | missense_variant | Exon 25 of 50 | 1 | ENSP00000415346.2 | |||
COL3A1 | ENST00000713745.1 | c.1703C>T | p.Pro568Leu | missense_variant | Exon 24 of 49 | ENSP00000519049.1 | ||||
COL3A1 | ENST00000713744.1 | c.1856C>T | p.Pro619Leu | missense_variant | Exon 26 of 49 | ENSP00000519048.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152016Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251170 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.000190 AC: 277AN: 1461510Hom.: 2 Cov.: 33 AF XY: 0.000204 AC XY: 148AN XY: 727078 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000105 AC: 16AN: 152016Hom.: 0 Cov.: 31 AF XY: 0.0000808 AC XY: 6AN XY: 74234 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, type 4 Uncertain:3Benign:1
Found in patient having exome sequencing for an unrelated indication. No known history of Ehlers-Danlos syndrome, type IV -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 619 of the COL3A1 protein (p.Pro619Leu). This variant is present in population databases (rs373838193, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with COL3A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 333057). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt COL3A1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This missense variant replaces proline with leucine at codon 619 of the COL3A1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 12/282552 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
This missense variant replaces proline with leucine at codon 619 of the COL3A1 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with small vessel disease and stroke (PMID: 31719132). This variant has been identified in 12/282552 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant summary: COL3A1 c.1856C>T (p.Pro619Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-05 in 251170 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in COL3A1 causing Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome, allowing no conclusion about variant significance. c.1856C>T has been observed in one individual affected with small vessel disease, without strong evidence for causality (Tan_2019). These report(s) do not provide unequivocal conclusions about association of the variant with Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 31719132). ClinVar contains an entry for this variant (Variation ID: 333057). Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:1
Identified in a patient with small vessel disease (PMID: 31719132); however, detailed clinical information was not provided; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Occurs in the triple helical domain at the X position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the X position is not a common mechanism of disease (HGMD); This variant is associated with the following publications: (PMID: 31719132) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at